[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PT1165108E - Utilizacao de um extracto de serenoa repens para o fabrico de um medicamento destinado ao tratamento do cancro da prostata. - Google Patents

Utilizacao de um extracto de serenoa repens para o fabrico de um medicamento destinado ao tratamento do cancro da prostata.

Info

Publication number
PT1165108E
PT1165108E PT00915254T PT00915254T PT1165108E PT 1165108 E PT1165108 E PT 1165108E PT 00915254 T PT00915254 T PT 00915254T PT 00915254 T PT00915254 T PT 00915254T PT 1165108 E PT1165108 E PT 1165108E
Authority
PT
Portugal
Prior art keywords
prostate cancer
extract
manufacture
treatment
serenoa repens
Prior art date
Application number
PT00915254T
Other languages
English (en)
Inventor
Henri Cousse
Pierre Fabre
Jean-Pierre Raynaud
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of PT1165108E publication Critical patent/PT1165108E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
PT00915254T 1999-03-30 2000-03-30 Utilizacao de um extracto de serenoa repens para o fabrico de um medicamento destinado ao tratamento do cancro da prostata. PT1165108E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9903959A FR2791573B1 (fr) 1999-03-30 1999-03-30 Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate

Publications (1)

Publication Number Publication Date
PT1165108E true PT1165108E (pt) 2003-10-31

Family

ID=9543805

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00915254T PT1165108E (pt) 1999-03-30 2000-03-30 Utilizacao de um extracto de serenoa repens para o fabrico de um medicamento destinado ao tratamento do cancro da prostata.

Country Status (15)

Country Link
US (1) US6599540B1 (pt)
EP (1) EP1165108B1 (pt)
JP (1) JP2003504306A (pt)
CN (1) CN1261142C (pt)
AT (1) ATE241375T1 (pt)
AU (1) AU774568B2 (pt)
BR (1) BR0009445A (pt)
CA (1) CA2370775C (pt)
DE (1) DE60003010T2 (pt)
DK (1) DK1165108T3 (pt)
ES (1) ES2199802T3 (pt)
FR (1) FR2791573B1 (pt)
MX (1) MXPA01009879A (pt)
PT (1) PT1165108E (pt)
WO (1) WO2000057892A1 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1488807A4 (en) 2002-03-11 2009-07-08 Takeda Pharmaceutical MEDICAMENTS FOR TREATING SEXUAL HORMONE DEPENDENT DISEASE
EP1827366B1 (en) 2004-11-25 2017-03-15 The University of Melbourne Stabilized calcium phosphate complexes
WO2006065599A1 (en) * 2004-12-17 2006-06-22 Bionovo, Inc. Method of using extracts of epimedium species
US7482029B2 (en) 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
BRPI0610885B1 (pt) 2005-06-07 2018-07-10 The University Of Melbourne Mineralização dental
PL1901702T3 (pl) 2005-06-24 2015-07-31 Univ Melbourne Kompleksy jonowe
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
JP5231252B2 (ja) 2006-02-09 2013-07-10 ザ ユニバーシティー オブ メルボルン 歯の石灰化のためのフッ化物組成物および方法
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
WO2009021196A1 (en) * 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of ligustrum lucidum and uses thereof
CA2698739A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of pueraria lobata willd. ohwi of the leguminosae family and uses thereof
EP2194999A4 (en) * 2007-09-07 2012-03-21 Bionovo Inc ESTROGENIC EXTRACTS OF ASTRAGALUS MEMBRANACEUS FISCH.BGE.VAR.MONGOLICUS BGE. THE FAMILY LEGUMINOSAE AND ITS APPLICATIONS
WO2009033025A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of asparagus conchinchinensis (lour.) merr of the liliaceae family and uses thereof
WO2009033075A1 (en) * 2007-09-07 2009-03-12 Bionovo. Inc. ESTROGENIC EXTRACTS OF Scuttelaria barbata D. DON OF THE LABIATAE FAMILY AND USES THEREOF
AU2008326429A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Anti-cancer therapy with an extract of scutellaria barbata
US20090130118A1 (en) * 2007-11-19 2009-05-21 Bionovo, Inc. Scutellaria barbata extract and combinations for the treatment of cancer
EP2222323A4 (en) * 2007-11-19 2012-07-25 Bionovo Inc PROCESS FOR PREPARING A CLEANED EXTRACT OF SCUTELLARIA BARBATA D. DON
CA2706313A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Methods of detecting and treatment of cancers using scuttelaria barbata extract
DE102008012988A1 (de) 2008-03-07 2009-09-10 S.W. Patentverwertungs Ltd. Zusammensetzung und Verwendungen zur Beeinflussung des Haarwachstums
CA2721191A1 (en) * 2008-04-14 2009-10-22 Bionovo, Inc. Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
EP2310024A4 (en) * 2008-05-06 2012-07-25 Bionovo Inc ESTROGENIC EXTRACTS FOR THE TREATMENT OF VAGINA AND VULVAATROPHY
WO2009149411A2 (en) * 2008-06-05 2009-12-10 Bionovo, Inc. Method of quantification of multiple bioactives from botanical compositons
US20090312437A1 (en) * 2008-06-06 2009-12-17 Bionovo, Inc., A Delaware Corporation Anthraquinones and Analogs from Rhuem palmatum for Treatment of Estrogen Receptor Beta-Mediated Conditions
DK2310023T3 (en) * 2008-07-31 2016-12-12 Sigma Tau Ind Farmaceuti COMPOSITION, WHICH INCLUDES green tea AND EXTRACT OF POMEGRANATE FOR USE IN PREVENTING OR REDUCING THE PROGRESSION OF PROSTATE CANCER
AU2009289644A1 (en) * 2008-09-03 2010-03-11 Bionovo, Inc. Methods and compositions for the treatment of cancer
WO2010129343A2 (en) * 2009-04-28 2010-11-11 Bionovo, Inc. Method of reducing fat accumulation and inducing weight loss
FR2963561B1 (fr) 2010-08-03 2013-04-12 Pf Medicament Composition pharmaceutique contenant un extrait de serenoa repens
DK3024428T3 (da) 2013-07-23 2021-01-18 Univ Melbourne Sammensætninger og fremgangsmåder til dental mineralisering
MY176788A (en) 2013-12-24 2020-08-21 Univ Melbourne Stabilized stannous compositions
CZ306733B6 (cs) * 2014-08-27 2017-05-31 Walmark, A.S. Doplněk stravy na bázi klikvy velkoplodé pro použití k oddálení biochemického návratu karcinomu prostaty
PL3595615T3 (pl) 2017-03-14 2024-05-13 The University Of Melbourne Leczenie zapalenia dziąseł

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes
FR2480754A1 (fr) * 1980-04-21 1981-10-23 Fabre Sa Pierre Procede d'obtention d'un extrait stable et desodorise de sabal serrulatum antiprostatique
IT1258305B (it) * 1992-04-10 1996-02-22 Zambeletti Spa L Composizioni farmaceutiche rettali per il trattamento dell'ipertrofia prostatica
US6039950A (en) * 1995-04-14 2000-03-21 University Of Southern California Pharmaceutical grade saw palmetto
US6107090A (en) * 1996-05-06 2000-08-22 Cornell Research Foundation, Inc. Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
US5665393A (en) * 1996-09-03 1997-09-09 International Medical Research, Inc. Herbal composition for treating prostate carcinoma
NZ509976A (en) * 1998-08-03 2003-08-29 Ronald E Prostate formula
US6399115B2 (en) * 1999-09-10 2002-06-04 Glenn Braswell Method and composition for the treatment of benign prostate hypertrophy (BPH) and prevention of prostate cancer
US6261607B1 (en) * 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
US6200573B1 (en) * 1999-12-03 2001-03-13 Starcor Pharmaceuticals, Inc. Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia

Also Published As

Publication number Publication date
WO2000057892A1 (fr) 2000-10-05
DK1165108T3 (da) 2003-09-22
FR2791573B1 (fr) 2003-04-11
US6599540B1 (en) 2003-07-29
BR0009445A (pt) 2002-01-08
FR2791573A1 (fr) 2000-10-06
CN1346277A (zh) 2002-04-24
ATE241375T1 (de) 2003-06-15
CN1261142C (zh) 2006-06-28
CA2370775C (fr) 2011-06-21
CA2370775A1 (fr) 2000-10-05
JP2003504306A (ja) 2003-02-04
EP1165108B1 (fr) 2003-05-28
AU3663100A (en) 2000-10-16
MXPA01009879A (es) 2002-05-06
DE60003010D1 (de) 2003-07-03
AU774568B2 (en) 2004-07-01
ES2199802T3 (es) 2004-03-01
DE60003010T2 (de) 2004-04-01
EP1165108A1 (fr) 2002-01-02

Similar Documents

Publication Publication Date Title
PT1165108E (pt) Utilizacao de um extracto de serenoa repens para o fabrico de um medicamento destinado ao tratamento do cancro da prostata.
ATE307608T1 (de) Kombination von doctaxel und rhumab her2 zür krebsbehandlung
CZ2000531A3 (en) Method of prevention or therapy of estrogen-dependent diseases and disorders
BR0209147A (pt) Terapia combinada que usa anticorpos anti-egfr e agentes anti-hormonais
MXPA03003960A (es) Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
BRPI0516177A (pt) oligorribonucleotìdios e métodos para uso dos mesmos para o tratamento da alopécia, insuficiência renal aguda e outras doenças
MY146533A (en) Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
IL155781A0 (en) Effective antitumor treatments
IL125776A (en) Use of a cimicifuga racemosa extract for the manufacture of a drug for treating estrogen-dependent tumors
NZ504928A (en) Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
PT1124566E (pt) Laxativo osmotico nao fermentado para o tratamentoe a prevencao dos cancros colorectais
AU2020327022A8 (en) Method of treating cancer
MXPA04001912A (es) Aminobenzofenonas novedosas.
MX2007006927A (es) Combinacion de inhibidor de tirosina cinasa y her-2/neu para terapia de cancer.
MD798G2 (ro) Metoda de tratament a cancerului mamar
WO2023060283A3 (en) Anti-trop2 antibody combination therapies and methods of use thereof
ATE345805T1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
WO2000061125A3 (fr) L'osanetant dans le traitement des troubles de l'humeur
BR0313789A (pt) Medicamento contendo disorazóis e seus derivados para o tratamento de doenças tumorais malignas e benignas
PT1161254E (pt) Tratamento de doenças auto-imunes com extracto de ginseng americano
Arcangeli et al. Multiple daily fractionation (MDF) in association with misonidazole (MIS): a two-year experience with head and neck cancer
TW202440098A (zh) 使用bet抑制劑之癌症組合療法
KR920700636A (ko) 인체의 악성 종양을 치료하기 위한 1,2-벤조피론 유도체의 용도
Shinohara et al. A Case of Chronic Nasal Obstruction Treated with Kampo Medicine and Acupuncture